NCI Starts SBIR Regulatory Help Effort | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute has started a new effort to help firms that have won Phase II funding under its Small Business Innovation Research program to work their way through the regulatory approval process.

The pilot Regulatory Assistance Program, open to new and recent SBIR and Small Business Technology Transfer grantees, will provide up to 30 hours of time with regulatory consultants to companies developing new medical devices or therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.